In fact, Goldman Sachs (GS) believes the S&P 500 will rise by just 5% this year as ‘Magnificent 7’ stocks have taken a ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

CNS Pharmaceuticals' Berubicin trial results show a favorable safety profile with no cardiotoxicity and comparable efficacy ...

Stocks Leading in March. In this article, we are going to take a look at where Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ...

Advisors Asset Management Inc. trimmed its stake in Regeneron Pharmaceuticals by 7.9%, selling 443 shares in the fourth ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

MIRA Pharmaceuticals signs letter of intent to acquire SKNY Pharmaceuticals, adding SKNY-1, a preclinical drug for weight ...

Investing in dividend growth stocks is a smart, reliable way to build passive income that lasts a lifetime, and it’s worth ...

Terns Pharmaceuticals, Inc.’s TERN share price has surged by 14.97%, which has investors questioning if this is right time to ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

On Monday, Arrowhead Pharmaceuticals, Inc. (NASDAQ ... upfront payment and $325 million through Sarepta stock. Price Action: ARWR stock is down 8.72% at $15.49 at the last check Monday.